APA (7th ed.) Citation

JI, S., LA, B., M, G., DF, M., MC, W., L, S., . . . L, S. (2026). Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: Results from an 8-week randomised Phase IIb trial. The British journal of dermatology. https://doi.org/10.1093/bjd/ljag296

Chicago Style (17th ed.) Citation

JI, Silverberg, Beck LA, Gooderham M, Murrell DF, Wiseman MC, Sørensen L, Jönsson PG, and Stein-Gold L. "Delgocitinib Cream Formulation Demonstrates a Dose-dependent Response in Adults with Mild to Severe Atopic Dermatitis: Results from an 8-week Randomised Phase IIb Trial." The British Journal of Dermatology 2026. https://doi.org/10.1093/bjd/ljag296.

MLA (9th ed.) Citation

JI, Silverberg, et al. "Delgocitinib Cream Formulation Demonstrates a Dose-dependent Response in Adults with Mild to Severe Atopic Dermatitis: Results from an 8-week Randomised Phase IIb Trial." The British Journal of Dermatology, 2026, https://doi.org/10.1093/bjd/ljag296.